FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA ...
Botox is a household name synonymous with wrinkle reduction and a youthful appearance. However, this powerful medication, derived from a purified neurotoxin, has a surprising array of uses that extend ...
NEW YORK (Reuters Health) - As a treatment for muscle stiffness in children with cerebral palsy, shots of botulinum toxin A, best known by the brand name Botox, are safe and produce measurable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback